Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07149207 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Eligibility criteria expanded, about 5 wordsv7 See this version in full on ClinicalTrials.gov ↗
  2. Start date changed from estimate of Jun 15, 2026 to May 4, 2026v6
  3. Primary completion pushed from Oct 2026 to Apr 7, 2028 Recruitment opened · Completion pushed from Dec 2026 to Apr 7, 2029 · Eligibility criteria expanded, about 173 words · 1 morev5 Show 4 more changesShow less
    • Recruitment opened
    • Completion pushed from Dec 2026 to Apr 7, 2029
    • Eligibility criteria expanded, about 173 words
    • Site details revised

    See this version in full on ClinicalTrials.gov ↗

  4. Start date: Feb 16, 2026 to Jun 15, 2026v4
  5. Start date: Jan 1, 2026 to Feb 16, 2026v3
  6. Start date: Oct 2025 to Jan 1, 2026v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is for adult patients with head and neck cancer who are at risk of recurrence. The purpose of this study is to evaluate whether the use of Indocyanine Green (ICG) dye allows for better identification of tumor tissue during surgical procedures. Participation will include standard of care visits along with administration of ICG dye and imaging during surgery. Participation in this study will last approximately 6 weeks.
Trial Details
NCT Number NCT07149207
Lead Sponsor Medical University of South Carolina
Conditions Squamous Cell Carcinoma Head and Neck Cancer (HNSCC), Margin Assessment
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov